Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Regen Biopharma Inc (RGBP)

Regen Biopharma Inc (RGBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade RGBP with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6201 +20.95%
on 03/27/24
0.9000 -16.67%
on 03/01/24
-0.0848 (-10.16%)
since 02/28/24
3-Month
0.6000 +25.00%
on 01/17/24
1.1200 -33.04%
on 01/30/24
+0.0350 (+4.90%)
since 12/28/23
52-Week
0.5222 +43.62%
on 12/18/23
2.6150 -71.32%
on 04/18/23
-1.1600 (-60.73%)
since 03/28/23

Most Recent Stories

More News
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on March 7, 2024

/CNW/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies,...

RGBP : 0.7500 (+1.35%)
RGBPP : 2.0200 (-36.88%)
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on February 7, 2024

/CNW/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies,...

RGBP : 0.7500 (+1.35%)
RGBPP : 2.0200 (-36.88%)
Regen BioPharma, Inc. Receives First Phase of Confirmatory Study

/PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) has previously discussed initiation of a series of experiments to validate its DuraCAR...

RGBP : 0.7500 (+1.35%)
RGBPP : 2.0200 (-36.88%)
Regen BioPharma Leverages Exosome Technologies to Broaden its Survivin Cancer Immunotherapy Portfolio

/PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell...

RGBP : 0.7500 (+1.35%)
RGBPP : 2.0200 (-36.88%)
Regen BioPharma, Inc. issues Message to the Shareholders from the Chairman And Chief Executive Officer

/PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) As 2022 comes to a close, I would like to highlight some our many accomplishments...

RGBP : 0.7500 (+1.35%)
RGBPP : 2.0200 (-36.88%)
Regen BioPharma Appoints Two New Scientific Advisory Board Members

/PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) announced that Dr. Ravinder Reddy, a Professor of Radiology at the University of...

RGBP : 0.7500 (+1.35%)
RGBPP : 2.0200 (-36.88%)
Regen BioPharma, Inc. Progresses Its DuraCAR Therapeutic

/PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) has previously discussed initiation of a series of experiments to validate its...

RGBP : 0.7500 (+1.35%)
RGBPP : 2.0200 (-36.88%)
Regen BioPharma Developing a Non-Exhaustible CAR-T Cell Therapeutic

/PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP)has recently discussed the use of CAR-T therapies in cancer treatment...

RGBP : 0.7500 (+1.35%)
RGBPP : 2.0200 (-36.88%)
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on November 9, 2022

/PRNewswire/ -- Regen BioPharma, Inc. (OTC-PINK: RGBP) (OTC-PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell...

RGBP : 0.7500 (+1.35%)
RGBPP : 2.0200 (-36.88%)
Regen BioPharma, Inc. Explores the CAR-T Therapeutic Space

/PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) has filed several patents over the last year on multiple ways to improve CAR-T...

RGBP : 0.7500 (+1.35%)
RGBPP : 2.0200 (-36.88%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.8307
2nd Resistance Point 0.7903
1st Resistance Point 0.7702
Last Price 0.7500
1st Support Level 0.7097
2nd Support Level 0.6693
3rd Support Level 0.6492

See More

52-Week High 2.6150
Fibonacci 61.8% 1.8156
Fibonacci 50% 1.5686
Fibonacci 38.2% 1.3216
Last Price 0.7500
52-Week Low 0.5222

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar